Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Oct. 17, 2022
Abstract
Intracerebral
hemorrhage
(ICH)
is
a
devasting
stroke
type
with
high
mortality
and
disability.
Inflammatory
response
induced
by
macrophages/microglia
(M/Ms)
activation
one
of
the
leading
causes
brain
damage
after
ICH.
The
anti-inflammatory
effects
resveratrol
(RSV)
have
already
been
evaluated
in
several
models
central
nervous
system
disease.
Therefore,
we
designed
current
study
to
assess
role
RSV
ICH
explore
its
downstream
mechanism
related
Sirt3.
autologous
artery
blood
injection
was
administrated
create
an
mouse
model.
M/Ms
specific
Sirt3
knockout
f/f
;
CX3CR1-Cre
(Sirt3
cKO)
used
evaluate
on
treatment.
Neuronal
function
hematoma
volume
were
assessed
indicate
damage.
pro-inflammatory
marker
(CD16)
cytokine
(TNF-α)
measured
inflammatory
effects.
Our
results
showed
that
treatment
alleviates
neurological
deficits,
reduces
apoptosis,
increases
clearance
day
7
In
addition,
effectively
suppressed
CD16
+
decreased
TNF-α
release.
cKO
mice,
protective
abolished,
indicating
potential
partially
due
signaling
activation.
could
be
promising
candidate
therapeutic
agent
for
target
inhibit
inflammation.
ACS Chemical Neuroscience,
Journal Year:
2024,
Volume and Issue:
15(9), P. 1828 - 1881
Published: April 22, 2024
Neurodegenerative
diseases
(NDs)
are
one
of
the
prominent
health
challenges
facing
contemporary
society,
and
many
efforts
have
been
made
to
overcome
(or)
control
it.
In
this
research
paper,
we
described
a
practical
one-pot
two-step
three-component
reaction
between
3,4-dihydronaphthalen-1(2H)-one
(1),
aryl(or
heteroaryl)glyoxal
monohydrates
(2a–h),
hydrazine
monohydrate
(NH2NH2•H2O)
for
regioselective
preparation
some
3-aryl(or
heteroaryl)-5,6-dihydrobenzo[h]cinnoline
derivatives
(3a–h).
After
synthesis
characterization
mentioned
cinnolines
(3a–h),
in
silico
multi-targeting
inhibitory
properties
these
heterocyclic
scaffolds
investigated
upon
various
Homo
sapiens-type
enzymes,
including
hMAO-A,
hMAO-B,
hAChE,
hBChE,
hBACE-1,
hBACE-2,
hNQO-1,
hNQO-2,
hnNOS,
hiNOS,
hPARP-1,
hPARP-2,
hLRRK-2(G2019S),
hGSK-3β,
hp38α
MAPK,
hJNK-3,
hOGA,
hNMDA
receptor,
hnSMase-2,
hIDO-1,
hCOMT,
hLIMK-1,
hLIMK-2,
hRIPK-1,
hUCH-L1,
hPARK-7,
hDHODH,
which
confirmed
their
functions
roles
neurodegenerative
(NDs),
based
on
molecular
docking
studies,
obtained
results
were
compared
with
wide
range
approved
drugs
well-known
(with
IC50,
EC50,
etc.)
compounds.
addition,
ADMET
prediction
analysis
was
performed
examine
prospective
drug
synthesized
compounds
The
from
studies
ADMET-related
data
demonstrated
that
series
heteroaryl)-5,6-dihydrobenzo[h]cinnolines
especially
hit
ones,
can
really
be
turned
into
potent
core
new
treatment
and/or
due
having
reactionable
locations,
they
able
further
organic
reactions
(such
as
cross-coupling
reactions),
expansion
(for
example,
using
other
types
monohydrates)
makes
avenue
designing
novel
efficient
purpose.
RSC Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
New
caffeine
analogues,
derived
from
theobromine
and
theophylline,
exhibit
potent
selective
acetylcholinesterase
inhibition,
positioning
them
as
promising
lead
compounds
for
the
development
of
novel
drugs
targeting
neurodegenerative
diseases.
New Journal of Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Oxadiazolone-fused
isoquinolines
were
synthesized
via
Rh(
iii
)-catalyzed
[4+2]
annulation
and
C–H
activation,
followed
by
acymethylation
products
with
antidiabetic
anti-inflammatory
potential.
Journal of Chemical Information and Modeling,
Journal Year:
2022,
Volume and Issue:
62(16), P. 3734 - 3751
Published: Aug. 8, 2022
Food
compounds
and
their
molecular
interactions
are
crucial
for
health
provide
new
chemotypes
targets
drug
nutraceutic
design.
Here,
we
retrieve
analyze
the
complete
set
of
published
food
with
human
proteins
using
FooDB
as
a
compound
ChEMBL
source
interactions.
The
data
analyzed
in
terms
19
target
classes
classes,
showing
small
fraction
assignment
(1.6%)
unraveling
multiple
gaps
chemobiological
space
these
molecules.
By
well-established
cheminformatic
approaches
[similarity
ensemble
approach
(SEA)
combined
maximum
Tanimoto
coefficient
to
nearest
bioactive,
"SEA
+
TC"],
achieve
much
enhanced
(64.2%),
filling
many
hypothesis
fast
focused
testing.
publishing
sets
analyses,
expect
resources
speed
up
full
clarification
compounds,
opening
opportunities
Expert Opinion on Drug Discovery,
Journal Year:
2023,
Volume and Issue:
18(8), P. 851 - 879
Published: June 19, 2023
Over
the
past
5
years,
we
have
witnessed
intense
research
activity
about
biological
potential
of
natural
products
(NPs)
as
human
monoamine
oxidase
B
(hMAO-B)
inhibitors.
Despite
promising
inhibitory
activity,
compounds
often
suffer
from
pharmacokinetic
lissues,
such
poor
aqueous
solubility,
extensive
metabolism,
and
low
bioavailability.This
review
provides
an
overview
current
landscape
NPs
selective
hMAO-B
inhibitors
highlights
their
use
a
starting
scaffold
to
design
(semi)synthetic
derivatives
overcome
therapeutic
(pharmacodynamic
pharmacokinetic)
limitations
obtain
more
robust
structure-activity
relationships
(SARs)
for
each
scaffold.All
scaffolds
herein
presented
displayed
broad
chemical
diversity.
The
knowledge
enzyme
allows
positive
correlations
associated
with
consumption
specific
food
or
possible
herb-drug
interactions
suggests
Medicinal
Chemists
how
address
functionalization
potent
compounds.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(1), P. 860 - 860
Published: Jan. 3, 2023
Several
psychosocial,
sleep/circadian,
and
cardiometabolic
disorders
have
intricately
interconnected
pathologies
involving
melatonin
disruption.
Therefore,
we
hypothesize
that
could
be
a
therapeutic
target
for
treating
potential
comorbid
diseases
associated
with
this
triad
of
psychosocial-sleep/circadian-cardiometabolic
disorders.
We
investigated
melatonin's
prediction
tractability
The
the
proposed
disorder
was
using
databases
from
Europe
PMC,
ChEMBL,
Open
Targets
Genetics,
Phenodigm,
PheWAS.
association
scores
receptors
MT1
MT2
were
explored
evidence
target-disease
predictions.
as
tractable
in
managing
supervised
machine
learning
to
identify
activities
cardiovascular,
neuronal,
metabolic
assays
at
cell,
tissue,
organism
levels
curated
ChEMBL
database.
Target-disease
visualization
done
by
graphs
created
"igraph"
library-based
scripts
displayed
Gephi
ForceAtlas
algorithm.
combined
PMC
(data
type:
text
mining),
drugs),
Genetics
Portal
genetic
associations),
PhenoDigm
animal
models),
PheWAS
associations)
yielded
types
varying
melatonin-disease
correlations.
Of
databases,
235
targeted
greater
than
0.2;
classify
per
disease
class:
37%
listed
psychosocial
disorders,
9%
sleep/circadian
54%
Using
learning,
546
or
experimental
predicted
measured
activity
identified
248
registered
trials,
144
phase
I
IV
trials
agonists
been
completed,
which
33.3%
59.7%
6.9%
Melatonin's
druggability
evidenced
evaluating
While
research
development
is
more
advanced,
scores,
substantial
on
discovery
cardiovascular
supports
continued
R&D
scores.
A
multiplatform
analysis
provided
an
integrative
assessment
investigations
may
justify
further
translational
research.